Key result
In conscious FVB/N neonate mice, heart rate increased linearly from postnatal day 2 to 14, with sex-based differences in heart rate and PR interval emerging only after weaning.
Observational (n=20)
Non-invasive ECG monitoring in conscious neonatal mice demonstrates that ECG intervals mature by day 12 while heart rate increases linearly until weaning, providing essential baseline data for preclinical models of pediatric arrhythmias.
Baseline neonatal mouse ECG data supports preclinical arrhythmia models; does not inform human pediatric practice without validation.
BACKGROUND: Electrocardiography remains the best diagnostic tool and therapeutic biomarker for a spectrum of pediatric diseases involving cardiac or autonomic nervous system defects. As genetic links to these disorders are established and transgenic mouse models produced in efforts to understand and treat them, there is a surprising lack of information on electrocardiograms (ECGs) and ECG abnormalities in neonate mice. This is likely due to the trauma and anaesthesia required of many legacy approaches to ECG recording in mice, exacerbated by the fragility of many mutant neonates. Here, we use a non-invasive system to characterize development of the heart rate and electrocardiogram throughout the growth of conscious neonate FVB/N mice. RESULTS: We examine ECG waveforms as early as two days after birth. At this point males and females demonstrate comparable heart rates that are 50% lower than adult mice. Neonatal mice exhibit very low heart rate variability. Within 12 days of birth PR, QRS and QTc interval durations are near adult values while heart rate continues to increase until weaning. Upon weaning FVB/N females quickly develop slower heart rates than males, though PR intervals are comparable between sexes until a later age. This suggests separate developmental events may contribute to these gender differences in electrocardiography. CONCLUSIONS: We provide insight with a new level of detail to the natural course of heart rate establishment in neonate mice. ECG can now be conveniently and repeatedly used in neonatal mice. This should serve to be of broad utility, facilitating further investigations into development of a diverse group of diseases and therapeutics in preclinical mouse studies.
No takes yet. Share an insight, caveat, or question.
Heier et al. (2010) conducted an observational in Healthy FVB/N neonate mice (n=20). Development and aging was evaluated on Heart rate and ECG interval durations (PR, QRS, QTc). In conscious FVB/N neonate mice, heart rate increased linearly from postnatal day 2 to 14, with sex-based differences in heart rate and PR interval emerging only after weaning.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: